GerosMicro
Financial Marketplace
Investment & Growth Platform
Preparing your investment experience
Initializing platform... 00%
FDA investigates tumour risk linked to Novartis’ Zolgensma gene therapy
  • thehindubusinessline.com
  • Posted On 07 November 2026

FDA investigates tumour risk linked to Novartis’ Zolgensma gene therapy

The US Food and Drug Administration said on Friday it was investigating a risk of neoplasia, or tumour formation including malignancy, associated with Novartis?...
Source: thehindubusinessline.com
Share Now

Live Support

We're here to help

CUSTOMER SUPPORT

Hello! How can we help you?

Send us a message and our Protocol Officer will assist you.

Connecting to support...